Sunday, March 11, 2012

Hospira Inc plans capacity expansion


US-based generic pharmaceutical firm Hospira Inc, which had acquired Orchid Chemicals and Pharmaceuticals Ltd’s generic injectables business in 2010, is in the process of infusing $275-$325 million (around Rs 1,300-1,600 crore) towards capacity expansion in India.
It has also initiated plans to qualify and validate manufacturing and related activities for certain oncology compounds in its joint venture with Ahmedabad-based Cadila Healthcare Ltd.

Hyderabad based Cheminnova Pharmaceuticals formed JV with Australia’s Rapid Nutrition

The Hyderabad based ‘Cheminnova’ an Indian pharmaceutical contract manufacturer, entered into equity based Joint Venture with Rapid Nutrition, one of the leading nutraceutical company in Australia.

Total Pageviews

Pages

Categories

Blogroll

Followers

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost